ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for bile duct cancer: liver radiation may boost standard treatment
Disease control Recruiting nowThis study looks at whether adding radiation to the liver can improve outcomes for people with advanced intrahepatic cholangiocarcinoma, a type of bile duct cancer that has spread. About 60 adults with at least one liver tumor 3 cm or larger will receive either standard therapy a…
Matched conditions: ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New drug targets rare bile duct cancer in 235-Patient trial
Disease control Recruiting nowThis study tests an experimental drug called HMPL-453 in people with advanced intrahepatic cholangiocarcinoma, a type of bile duct cancer, that has a specific genetic change (FGFR2 fusion). The trial aims to see how well the drug shrinks tumors. About 235 adults will take the dru…
Matched conditions: ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Hutchmed • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC